[1] 孙晨龙,任明华.高龄高危患者良性前列腺增生微创治疗新进展[J].临床与病理杂志,2020,40(11):3034-3039.
[2] 顾君,何泽喜,栾婷,等.良性前列腺增生与膀胱癌相关性的研究进展[J].医学综述,2022,28(13):2590-2595.
[3] CONOR M DEVLIN,MATTHEW S SIMMS,NORMAN J MAITLAND.Benign Prostatic Hyperplasia-What Do We Know?[J].BJU International,2021,127:389-399.
[4] SKINDER DANIELLE,ZACHARIA ILANA,STUDIN JILLIAN,et al.Benign Prostatic Hyperplasia:A Clinical Review[J].Journal of the American Academy of Physician Assistants,2016,29(8):19-23.
[5] OKADA KOICHI,TAKEZAWA KANTARO,TSUJIMURA GO,et al.Localization and Potential Role of Prostate Microbiota[J].Frontiers in Cellular and Infection Microbiology,2022,12:1048319.DOI:10.3389/fcimb.2022.1048319.
[6] 许伟琼,胡汉斌,曾小花,等.前列腺增生患者电切手术后脓尿、菌尿状况改变研究[J].热带医学杂志,2015,15(7):963-965.
[7] CAMILLE VUICHOUD,KEVIN R LOUGHLIN.Benign Prostatic Hyperplasia:Epidemiology,Economics and Evaluation[J].Canadian Journal of Urology,2015(Suppl 1):1-6.
[8] SHOSKES DANIEL A,ALTEMUS JESSICA,POLACHWICH ALAN S,et al.The Urinary Microbiome Differs Significantly Between Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Controls as Well as Between Patients with Different Clinical Phenotypes[J].Urology,2016,92:26-32.
[9] NICKEL J CURTIS,STEPHENS ALISA,LANDIS J RICHARD,et al.Search for Microorganisms in Men with Urologic Chronic Pelvic Pain Syndrome:A Culture-Independent Analysis in the MAPP Research Network[J].The Journal of Urology,2015,194(1):127-135.
[10] POPOVIC VILJEMKA BUCEVIC,ITUM MARIJAN,CHOW CHERYL-ELIMIANE T,et al.The Urinary Microbiome Associated with Bladder Cancer[J].Scientific Reports,2018,8(1):12157.DOI:10.1038/s41598-018-29054-w.
[11] LI Jiaren,LI Youyou,ZHOU Liang,et al.The Human Microbiome and Benign Prostatic Hyperplasia:Current Understandings and Clinical Implications[J].Microbiological Research,2024,281:127596.DOI:10.1016/j.micres.2023.127596.
[12] LEE HSIANG-YING,WANG JIUNN-WEI,JUAN YUNG-SHUN,et al.The Impact of Urine Microbiota in Patients with Lower Urinary Tract Symptoms[J].Annals of Clinical Microbiology and Antimicrobials,2021,20(1):23.DOI:10.1186/s12941-021-00428-9.
[13] JONES-FREEMAN BERNADETTE,CHONWERAWONG MICHELLE,MARCELINO VANESSE R,et al.The Microbiome and Host Mucosal Interactions in Urinary Tract Diseases[J].Mucosal Immunology,2021,14(4):779-792.
[14] MARAND AIDA JAVAN BALEGH,BAARS CLEO,HEESAKKERS JOHN,et al.Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and Without Detrusor Overactivity on Urodynamic Measurements[J].Life,2023,13(5):1199.DOI:10.3390/life13051199.
[15] 孔祥斌,董治龙,王志平.人体微生物组与慢性前列腺炎/慢性骨盆疼痛综合征相关研究进展[J].中华男科学杂志,2022,28(3):243-246.
[16] NEUGENT MICHAEL L,HULYALKAR NEHA V,NGUYEN VIVIAN H,et al.Advances in Understanding the Human Urinary Microbiome and Its Potential Role in Urinary Tract Infection[J].mBio,2020,11(2):e00218-e00220.
[17] YU Haining,MENG Hongzhou,ZHOU Feng,et al.Urinary Microbiota in Patients with Prostate Cancer and Benign Prostatic Hyperplasia[J].Archives of Medical Science,2015,11(2):385-394.
[18] SHRESTHA EVA,WHITE JAMES R,YU Shuhan,et al.Profiling the Urinary Microbiome in Men with Positive Versus Negative Biopsies for Prostate Cancer[J].The Journal of Urology,2018,199(1):161-171.
[19] WINNENBURG RAINER,BALDWIN THOMAS K,URBAN MARTIN,et al.PHI-Base:A New Database for Pathogen Host Interactions[J].Nucleic Acids Research,2006,34(Suppl 1):D459-D464.
[20] CHEN Lihong,YANG Jian,YU Jun,et al.VFDB:A Reference Database for Bacterial Virulence Factors[J].Nucleic Acids Research,2005,33(Suppl 1):D325-D328.
|